L&C BIO Co.,LTD (KOSDAQ: A290650)
Health Care · Biotechnology · KR
₩56,400.00
+5.03% today · +13.0% 1Y
L&C BIO Co.,LTD (KOSDAQ: A290650) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.13B.
Over the last twelve months the share price has gained 13.0%, trading between 42.15K and 125.00K.
Tweenvest scores L&C BIO Co.,LTD across four factors: quality 61/100, value 66/100, dividend 3/100. Its strongest factor is value.
A290650 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.13B
- Revenue (TTM)
- $75.10M
- P/E
- —
- EPS
- -5,981.52
- Dividend yield
- 0.09%
- Beta (5Y)
- 1.51
- 52-week high
- ₩125,000.00
- 52-week low
- ₩42,150.00
- Avg volume (3M)
- —
- Shares outstanding
- 26.97M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Aimed Bio Inc.KOSDAQ: A0009K0 | $1.17B | ₩24,250.00 | -2.22% |
| Bicara Therapeutics Inc.NasdaqGM: BCAX | $1.16B | $17.25 | -1.43% |
| Amoy Diagnostics Co., Ltd.SZSE: 300685 | $1.16B | CN¥20.30 | -4.87% |
| Nanjing Leads Biolabs Co., Ltd.SEHK: 9887 | $1.13B | HK$45.56 | -9.69% |
| Janux Therapeutics, Inc.NasdaqGM: JANX | $1.12B | $18.17 | -1.20% |
| HOB Biotech Group Corp.,LtdSHSE: 688656 | $1.12B | CN¥120.00 | -8.90% |
| China Resources Boya Bio-pharmaceutical Group Co.,LtdSZSE: 300294 | $1.12B | CN¥14.88 | -0.40% |
| Oncolys BioPharma Inc.TSE: 4588 | $1.11B | ¥5,970.00 | -0.17% |
Figures last refreshed Oct 11, 2026.